|
1
|
Liu X and Cho WC: Precision medicine in
immune checkpoint blockade therapy for non-small cell lung cancer.
Clin Transl Med. 6:72017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kunz M, Wolf B, Schulze H, Atlan D, Walles
T, Walles H and Dandekar T: Non-coding RNAs in lung cancer:
Contribution of bioinformatics analysis to the development of
non-invasive diagnostic tools. Genes. 8:pii: E8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thean LF, Wong YH, Lo M, Loi C, Chew MH,
Tang CL and Cheah PY: Chromosome 19q13 disruption alters
expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to
FAP-like phenotype in APC mutation-negative familial colorectal
cancer patients. PLoS One. 12:e1737722017. View Article : Google Scholar
|
|
4
|
Li LJ, Chai Y, Guo XJ, Chu SL and Zhang
LS: The effects of the long non-coding RNA MALAT-1 regulated
autophagy-related signaling pathway on chemotherapy resistance in
diffuse large B-cell lymphoma. Biomed Pharmacother. 89:939–948.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang LM, Wang P, Liu XM and Zhang YJ:
LncRNA SUMO1P3 drives colon cancer growth, metastasis and
angiogenesis. Am J Transl Res. 9:5461–5472. 2017.PubMed/NCBI
|
|
6
|
Li AH and Zhang HH: Overexpression of
lncRNA MNX1-AS1 is associated with poor clinical outcome in
epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 21:5618–5623.
2017.PubMed/NCBI
|
|
7
|
Huang Y, Zhang J, Hou L, Wang G, Liu H,
Zhang R, Chen X and Zhu J: LncRNA AK023391 promotes tumorigenesis
and invasion of gastric cancer through activation of the PI3K/Akt
signaling pathway. J Exp Clin Cancer Res. 36:1942017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q,
Yin R and Xu L: Long noncoding RNA CCAT2 correlates with smoking in
esophageal squamous cell carcinoma. Tumour Biol. 36:5523–5528.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian FM, Meng FQ and Wang XB:
Overexpression of long-noncoding RNA ZFAS1 decreases survival in
human NSCLC patients. Eur Rev Med Pharmacol Sci. 20:5126–5131.
2016.PubMed/NCBI
|
|
10
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasagi Y, Oki E, Ando K, Ito S, Iguchi T,
Sugiyama M, Nakashima Y, Ohgaki K, Saeki H, Mimori K, et al: The
expression of CCAT2, a novel long noncoding RNA transcript, and
rs6983267 single-mucleotide polymorphism genotypes in colorectal
cancers. Oncology. 92:48–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lyu X, Li J, Yun X, Huang R, Deng X, Wang
Y, Chen Y and Xiao G: miR-181a-5p, an inducer of Wnt-signaling,
facilitates cell proliferation in acute lymphoblastic leukemia.
Oncol Rep. 37:1469–1476. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu XB, Zhang ZC, Han GS, Han JZ and Qiu
DP: Overexpression of miR-214 promotes the progression of human
osteosarcoma by regulating the Wnt/β-catenin signaling pathway. Mol
Med Rep. 15:1884–1892. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lecarpentier Y, Claes V, Vallée A and
Hébert JL: Interactions between PPAR gamma and the canonical
Wnt/beta-catenin pathway in type 2 diabetes and colon cancer. PPAR
Res. 2017:58790902017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo H, Hu G, Yang Q, Zhang P, Kuang W, Zhu
X and Wu L: Knockdown of long non-coding RNA CCAT2 suppressed
proliferation and migration of glioma cells. Oncotarget.
7:81806–81814. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma Y, Hu X, Shang C, Zhong M and Guo Y:
Silencing of long non-coding RNA CCAT2 depressed malignancy of oral
squamous cell carcinoma via Wnt/β-catenin pathway. Tumour Biol.
39:10104283177176702017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sarrafzadeh Sh, Geranpayeh L, Tasharrofi
B, Soudyab M, Nikpayam E, Iranpour M, Mirfakhraie R, Gharesouran J
and Ghafouri-Fard S and Ghafouri-Fard S: Expression study and
clinical correlations of MYC and CCAT2 in breast cancer patients.
Iran Biomed J. 21:303–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang JL, Liao Y, Qiu MX, Li J and An Y:
Long non-coding RNA CCAT2 promotes cell proliferation and invasion
through regulating Wnt/β-catenin signaling pathway in clear cell
renal cell carcinoma. Tumour Biol. 39:1010428317711312017.
View Article : Google Scholar
|
|
19
|
Meryet-Figuière M, Lambert B, Gauduchon P,
Vigneron N, Brotin E, Poulain L and Denoyelle C: An overview of
long non-coding RNAs in ovarian cancers. Oncotarget. 7:44719–44734.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L
and Yin R: CCAT2 is a lung adenocarcinoma-specific long non-coding
RNA and promotes invasion of non-small cell lung cancer. Tumour
Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ
and Hu JH: Long non-coding RNA CCAT2 is up-regulated in gastric
cancer and associated with poor prognosis. Int J Clin Exp Pathol.
8:779–785. 2015.PubMed/NCBI
|
|
22
|
Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and
Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer
proliferation and invasion by regulating the E-cadherin and LATS2.
Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
|
|
23
|
Zhao Z, Wang J, Wang S, Chang H, Zhang T
and Qu J: LncRNA CCAT2 promotes tumorigenesis by over-expressed
Pokemon in non-small cell lung cancer. Biomed Pharmacother.
87:692–697. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sokol SY: Spatial and temporal aspects of
Wnt signaling and planar cell polarity during vertebrate embryonic
development. Semin Cell Dev Biol. 42:78–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Jiang HY, Zhang LK, Xu WL, Qiao
YT, Zhu XG, Liu W, Zheng QQ and Hua ZC: C-FLIPL modulated
Wnt/β-catenin activation via association with TIP49 protein. J Biol
Chem. 292:2132–2142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brautigam C, Raggioli A and Winter J: The
Wnt/β-catenin pathway regulates the expression of the miR-302
cluster in mouse ESCs and P19 cells. PLoS One. 8:e753152013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Picco G, Petti C, Centonze A, Torchiaro E,
Crisafulli G, Novara L, Acquaviva A, Bardelli A and Medico E: Loss
of AXIN1 drives acquired resistance to WNT pathway blockade in
colorectal cancer cells carrying RSPO3 fusions. EMBO Mol Med.
9:2932017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai Y, He J and Zhang D: Long noncoding
RNA CCAT2 promotes breast tumor growth by regulating the Wnt
signaling pathway. Onco Targets Ther. 8:2657–2664. 2015.PubMed/NCBI
|
